Siren, L.L.C. Lexicon Pharmaceuticals, Inc. Transaction History
Siren, L.L.C.
- $2.26 Trillion
- Q4 2024
A detailed history of Siren, L.L.C. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 38,918,903 shares of LXRX stock, worth $30.4 Million. This represents 1.27% of its overall portfolio holdings.
Number of Shares
38,918,903
Previous 38,918,903
-0.0%
Holding current value
$30.4 Million
Previous $61.1 Billion
52.87%
% of portfolio
1.27%
Previous 3.05%
Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
132Shares Held
245MCall Options Held
52KPut Options Held
178K-
Artal Group S.A. Luxembourg, N4136MShares$106 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.71 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$7.71 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.99MShares$7.01 Million0.02% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY7.56MShares$5.9 Million0.04% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $147M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...